| |
|
|
|
Cleveland BioLabs Inc.  
|
|
1.6 -0.07 (-0.04%) |
03-22 16:00 |
|
Open: |
1.63 |
Pre close: |
1.67 |
Target:
|
2.09
|
|
High: |
1.68 |
Low: |
1.596 |
Resistance:
|
1.79
2.16
|
|
Volume: |
8,228 |
Market Cap: |
18M |
Support:
|
1.20
1.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.67
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
1.54  |
Signal(12,26,9): |
0.07 |
|
MA(100): |
1.55 |
Stochastic Oscillator |
%K(14,3):
|
47.36 |
|
MA(250): |
2.06 |
%D(3): |
49.01 |
|
Average Volume(K) |
3-Month: |
1201
|
52-Week |
High:
|
3.44 |
|
10-Days: |
943 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
51.53 |
Change(%): |
-49.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-966.0 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-51.0 |
Shares Float (M) |
7.64 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-72.9 |
% Held by Institutions |
5.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
146.140 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.61 |
P/S |
180800000.00 |
|
Operating Margin |
-421.71 |
Levered Free Cash Flow
(M) |
-3.88 |
P/CF |
-3.92 |
|
|
|
|
|
|
